Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders

Glucosidase 2 subunit beta

The PRKCSH gene encodes a glycosidase which is involved in glycan formation in the endoplasmatic reticulum. Mutations cause autosomal dominant polycastic liver disease type 1.


Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Research Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA
Clinic Method Massive parallel sequencing
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

Polycystic liver disease 1



Trombetta ES et. al. (1996) Endoplasmic reticulum glucosidase II is composed of a catalytic subunit, conserved from yeast to mammals, and a tightly bound noncatalytic HDEL-containing subunit.


Sakai K et. al. (1989) Isolation of cDNAs encoding a substrate for protein kinase C: nucleotide sequence and chromosomal mapping of the gene for a human 80K protein.


Reynolds DM et. al. (2000) Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1.


Li A et. al. (2003) Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.


Drenth JP et. al. (2003) Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.


Gao H et. al. (2010) PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation.


Fedeles SV et. al. (2011) A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation.

Update: Sept. 26, 2018